Holen Sie sich die Stockscreener-App
4.595
3.67%
-0.175
Handel nachbörslich:
4.85
0.255
+5.55%
Finanzdaten der Larimar Therapeutics Inc-Aktie (LRMR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
78.11%
49.50
|
27.79 | 31.19 | 31.29 | 18.26 |
| Operating Income/Loss |
78.11%
-49.50
|
-27.79 | -31.19 | -31.29 | -18.26 |
| Nonoperating Income/Loss |
10.99%
1.787
|
1.61 | 1.907 | 2.469 | 2.765 |
| Income/Loss From Continuing Operations Before Tax |
82.23%
-47.71
|
-26.18 | -29.28 | -28.82 | -15.50 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
82.23%
-47.71
|
-26.18 | -29.28 | -28.82 | -15.50 |
|
Net Income/Loss
|
82.23%
-47.71
|
-26.18 | -29.28 | -28.82 | -15.50 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
22.33%
78.32
|
64.03 | 63.96 | 0.8564 | 63.81 |
| Diluted Average Shares |
22.33%
78.32
|
64.03 | 63.96 | 0.8564 | 63.81 |
| Basic Earnings Per Share |
48.78%
-0.61
|
-0.41 | -0.46 | -0.46 | -0.24 |
| Diluted Earnings Per Share |
48.78%
-0.61
|
-0.41 | -0.46 | -0.46 | -0.24 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):